Journal
/
/
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
DOI:

07:25 min

September 25, 2019

, , ,

Chapters

  • 00:04Title
  • 00:34Antigen (Ag)‐ Specific CD8+ T cell Generation
  • 02:01Hydrodynamic Herpes B Virus (HBV) Plasmid Delivery for HBV Replication Induction
  • 02:43HBV Replication Reduction
  • 03:38HBV Replication Reduction Analysis
  • 05:30Results: Representative Effects of Stem Cell-Derived Viral Ag-Specific T Lymphocyte HBV Replication Suppression
  • 06:58Conclusion

Summary

Automatic Translation

Presented here is a protocol for the effective suppression of hepatitis B virus (HBV) replication in mice by utilizing adoptive cell transfer (ACT) of stem cell-derived viral antigen (Ag)-specific T lymphocytes. This procedure may be adapted for potential ACT-based immunotherapy of HBV infection.

Related Videos

Read Article